16 applications cleared under PLI for drug intermediates, APIs
April 13, 2021
Under the scheme, 14 applications have been approved with a committed investment of ₹873.93 crore - funfunphoto
Under the scheme, 14 applications have been approved with a committed investment of ₹873.93 crore - funfunphoto×
Companies have committed investment of ₹348.7 crore, seek to create 3,042 jobs A total of 16 applications have been approved under the Production-Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical key starting materials (KSMs)/drug intermediates and active pharmaceutical ingredients (APIs) with a total committed investment of ₹348.70 crore and employment generation of about 3,042 by the companies.
“The commercial production of these plants is projected to commence from April 1, 2023,” per an official release from the Ministry of Chemicals and Fertiliser on Tuesday. Companies that received a nod for their proposals include Hono